Recent Press Releases

Achilles Receives Cigna Foundation Grant to Study Effect of Running on Autism

--$100,000 World of Difference grant will fund research lacking today

BLOOMFIELD, Conn., July 1, 2014

Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE® Antibody Blinatumomab In Acute Lymphoblastic Leukemia

Breakthrough Designation Reinforces Significant Unmet Need in the Treatment of This Highly Aggressive Cancer

THOUSAND OAKS, Calif.

Novartis statement on employee oversight charges in Japan

Novartis Pharmaceuticals said today that although NPKK has not yet received official notification, NPKK understands that the Tokyo District Prosecutor's Office (TPO) has publicly disclosed that...

More MSF patients with DR-TB gain access to dramatically cheaper version of life-saving drug

More MSF patients with DR-TB gain access to dramatically cheaper version of life-saving drug Patients & MSF doctors elated as MCC approval for MSF to use generic linezolid paves the way for...

Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for Use of KALYDECO(R) (ivacaftor) in People 18 and Older with Cystic Fibrosis who have the R117H Mutation

Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for Use of KALYDECO(R) (ivacaftor) in People 18 and Older with Cystic Fibrosis who have the R117H Mutation...

Producers of High Quality, Low Cost Generic Medicines Organize, "Coalition of Affordable Care" is formed - U.S.-based India First Group to Lead the Charge

Producers of High Quality, Low Cost Generic Medicines Organize, "Coalition of Affordable Care" is formed - U.S.-based India First Group to Lead the Charge WASHINGTON, Jun 25, 2014 (BUSINESS...

CHMP Recommends Lilly and Boehringer Ingelheim's New Insulin Glargine Product for Approval in the European Union

First biosimilar insulin to receive CHMP positive opinion in the EU

INDIANAPOLIS and INGELHEIM, Germany<

CHMP Recommends Lilly and Boehringer Ingelheim's Investigational New Insulin Glargine Product for Approval in the European Union

First biosimilar insulin to receive CHMP positive opinion in the EU

INDIANAPOLIS and RIDGEFIELD, Conn.,

Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations

-In Europe, approximately 250 people ages 6 and older have one of 8 additional gating mutations- -KALYDECO is the first medicine to treat the underlying cause of CF in people with non-G551D...

Eliquis® (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE

PRINCETON, N.J. & NEW YORK, Jun 27, 2014 (BUSINESS WIRE) -- Bristol-Myers Squibb Company BMY -0.74% and Pfizer Inc. PFE -0.14% today announced that the Committee for Medicinal Products for...

Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor) in Eight Non-G551D Gating Mutations

Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor) in Eight Non-G551D Gating Mutations -In Europe, approximately 250 people ages 6 and older have one of 8 additional gating...

CHMP recommends EU approval of Roche's Avastin for platinum-resistant recurrent ovarian cancer

CHMP recommends EU approval of Roche's Avastin for platinum-resistant recurrent ovarian cancer CHMP recommends EU approval of Roche's Avastin for platinum-resistant recurrent ovarian cancer Avastin...

CHMP Recommends Lilly and Boehringer Ingelheim's Investigational New Insulin Glargine Product for Approval in the European Union

CHMP Recommends Lilly and Boehringer Ingelheim's Investigational New Insulin Glargine Product for Approval in the European Union INDIANAPOLIS and RIDGEFIELD, Conn., June 27, 2014 /PRNewswire/ --...

Gilead Submits New Drug Application to Japan's Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C

Gilead Submits New Drug Application to Japan's Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C If Approved, Sofosbuvir Would Be the First All-Oral Treatment...

EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union

EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union TARRYTOWN, N.Y., June 27, 2014 /PRNewswire/ --...

Boehringer Ingelheim's Investigational Antidote for Pradaxa® (dabigatran etexilate mesylate) Receives FDA Breakthrough Therapy Designation

Boehringer Ingelheim's Investigational Antidote for Pradaxa® (dabigatran etexilate mesylate) Receives FDA Breakthrough Therapy Designation Idarucizumab being evaluated to specifically reverse...

Diabetes Scholars Foundation Announces 2014 Scholarship Recipients

Lilly Diabetes grants $200,000 for scholarships

ROLLING MEADOWS, Ill. and INDIANAPOLIS,

Abbott Hosts Conference Call for Second-Quarter Earnings

ABBOTT PARK, Ill., June 25, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2014 financial results on